Taysha Gene Therapies Inc. Soared
Tue, Aug 29, 2023 at 07:02 PM
Taysha Gene Therapies Inc. (TSHA:NASDAQ) rocketted at $3.38, representing a gain of 42%. On Tue, Aug 29, 2023, TSHA:NASDAQ touched a New 2-Week High of $3.38. The stock appeared on our News Catalysts scanner on Thu, Aug 24, 2023 at 09:10 AM in the 'BIOTECH' category. From Tue, Aug 15, 2023, the stock recorded 60.00% Up Days and 45.45% Green Days
About Taysha Gene Therapies Inc. (TSHA:NASDAQ)
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease.
Top 10 Gainers:
- Axcella Health Inc. (AXLA:NASDAQ), 298.94%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 53.61%
- Signature Bank (SBNY:NASDAQ), 50%
- Xinyuan Real Estate Co., Ltd. (XIN:NYSE), 48.55%
- Taysha Gene Therapies Inc. (TSHA:NASDAQ), 42.02%
- Akso Health Group (AHG:NASDAQ), 37.74%
- Esports Technologies Inc. (EBET:NASDAQ), 37.53%
- IronNet Inc. (IRNT:NYSE), 29.03%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 28.81%
- UP Fintech Holding Limited (TIGR:NASDAQ), 28.53%